II
XERS icon

Ishara Investments’s Xeris Biopharma Holdings XERS Stock Holding History

Ishara Investments’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.74M Buy
1,230,000
+205,000
+20% +$1.31M 7.16% 2
2026
Q1 		$5.95M Buy
1,025,000
+225,000
+28% +$1.49M 5.63% 4
2025
Q4 		$6.28M Buy
+800,000
New +$6.3M 7.18% 2

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ishara Investments's XERS Position: Q2 2026 in Review

Ishara Investments increased its Xeris Biopharma Holdings (XERS) stake by 20% in Q2 2026, buying an estimated $1.31M and bringing the position to 1,230,000 shares worth $9.74M. The position accounts for 7.16% of the portfolio, ranked #2.

Ishara Investments first reported a position in XERS in Q4 2025 and has held it in 3 quarters since. 239 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Ishara Investments held 1,230,000 shares of Xeris Biopharma Holdings worth $9.74M as of Q2 2026.
  • Ishara Investments bought 205,000 Xeris Biopharma Holdings shares in Q2 2026, an estimated $1.31M.
  • Xeris Biopharma Holdings made up 7.16% of Ishara Investments's portfolio in Q2 2026, its #2 holding.
  • Ishara Investments first reported a position in Xeris Biopharma Holdings in Q4 2025 and has held it in 3 quarters since.
  • 239 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Ishara Investments's 13F filing for Q2 2026, filed 14 Aug 2026.